Allergy drug repurposed to repair damaged nerves in vision disorder
NCT ID NCT02521311
Summary
This study is testing whether clemastine, an older allergy medication, can help repair damaged nerve coatings in people with recent optic neuritis. Researchers will enroll 90 participants who developed optic neuritis within the past 3 weeks to receive either clemastine or a placebo for 9 months. The main goal is to see if the drug helps restore vision by promoting myelin repair around optic nerves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94158, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.